0001114220-17-000040.txt : 20171031
0001114220-17-000040.hdr.sgml : 20171031
20171031161141
ACCESSION NUMBER: 0001114220-17-000040
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171030
FILED AS OF DATE: 20171031
DATE AS OF CHANGE: 20171031
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Madison Greg
CENTRAL INDEX KEY: 0001564955
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30929
FILM NUMBER: 171165841
MAIL ADDRESS:
STREET 1: ONE MARINA PARK DRIVE
CITY: LEXINGTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001114220
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 134087132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MARINA PARK DR.
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-466-3500
MAIL ADDRESS:
STREET 1: ONE MARINA PARK DR.
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
wf-form4_150948068741523.xml
FORM 4
X0306
4
2017-10-30
0
0001114220
KERYX BIOPHARMACEUTICALS INC
KERX
0001564955
Madison Greg
C/O KERYX BIOPHARMACEUTICALS, INC.
ONE MARINA PARK DRIVE, 12TH FLOOR
BOSTON
MA
02210
1
1
0
0
President and CEO
Common Stock
2017-10-30
4
S
0
4055
6.03
D
368687
D
Sale of a total of 4,055 shares of common stock was made in order to satisfy Mr. Madison's income tax withholding obligation upon the vesting of 12,813 shares of restricted stock on October 27, 2017. Mr. Madison had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
Includes 216,882 shares of restricted stock.
/s/ Brian Adams, Attorney-in-Fact
2017-10-31